Biomarker Research Advancing, But More Needs to Be Done

Anyone who reads the news and takes an interest in developments in the medical world can't help but have seen the growth in coverage of biomarkers. They are being used in various areas of medical research by organisations all over the globe, and their use is having positive effects on research efforts. But while growth in terms of knowledge of biomarkers and what they can achieve is certainly taking place, more data is needed to really push this area of medical research forward.

By integrating biomarkers into the drug development process more widely, fresh data can be gathered and the impact of biomarkers will be more profound. Fortunately there are a significant number of individuals and companies that believe in the potential of biomarkers and are fully committed to using them as an integral part of the research process. And while good progress is undoubtedly being made, more companies need to start integrating biomarkers into their own research efforts in order for them to achieve regulatory status. This in turn will mean that biomarkers can be used as part of the decision making process during clinical trials, and the importance of this cannot be stressed highly enough.

It is positive news then that biomarkers are being used widely, both by small laboratories and by multi-national companies with incredible budgets. The wider integration of biomarkers is the key as this will in turn provide more data and increase knowledge and understanding. Experts around the world have got behind biomarkers and stood up to express their belief in them. This is vital if biomarkers are to be pushed forward and reach their true potential, helping to make life easier for patients suffering from diseases, and helping to identify diseases before they take hold.

Of course for companies, the use of biomarkers makes financial sense as they are able to use them to reduce attrition rates during the final stages of the research process. Being able to remove unsuitable substances from a process can save a considerable amount of time and money and this is critical for a firm in the pharmaceutical industry where competition is extreme and the benefits of discovering a new drug can be astronomical.

Biomarkers are critical to the future of medical research and undertaking further work is the only way to build a larger biomarker database and help further knowledge and understanding across the world of medicine.